Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA.
Eur Urol. 2013 Jul;64(1):85-92. doi: 10.1016/j.eururo.2012.09.035. Epub 2012 Sep 25.
The incidence of infected urolithiasis is unknown, and evidence describing the optimal management strategy for obstruction is equivocal.
To examine the trends of infected urolithiasis in the United States, the practice patterns of competing treatment modalities, and to compare adverse outcomes.
DESIGN, SETTING, AND PARTICIPANTS: A weighted estimate of 396385 adult patients hospitalized with infected urolithiasis was extracted from the Nationwide Inpatient Sample, 1999-2009.
Time trend analysis examined the incidence of infected urolithiasis and associated sepsis, as well as rates of retrograde ureteral catheterization and percutaneous nephrostomy (PCN) for urgent/emergent decompression. Propensity-score matching compared the rates of adverse outcomes between approaches.
Between 1999 and 2009, the incidence of infected urolithiasis in women increased from 15.5 (95% confidence interval [CI], 15.3-15.6) to 27.6 (27.4-27.8)/100 000); men increased from 7.8 (7.7-7.9) to 12.1 (12.0-12.3)/100000. Rates of associated sepsis increased from 6.9% to 8.5% (p=0.013), and severe sepsis increased from 1.7% to 3.2% (p<0.001); mortality rates remained stable at 0.25-0.20% (p=0.150). Among those undergoing immediate decompression, 113 459 (28.6%), PCN utilization decreased from 16.1% to 11.2% (p=0.001), with significant regional variability. In matched analysis, PCN showed higher rates of sepsis (odds ratio [OR]: 1.63; 95% CI, 1.52-1.74), severe sepsis (OR: 2.28; 95% CI, 2.06-2.52), prolonged length of stay (OR: 3.18; 95% CI, 3.01-3.34), elevated hospital charges (OR: 2.71; 95%CI, 2.57-2.85), and mortality (OR: 3.14; 95%CI, 13-4.63). However, observational data preclude the assessment of timing between outcome and intervention, and disease severity.
Between 1999 and 2009, women were twice as likely to have infected urolithiasis. Rates of associated sepsis and severe sepsis increased, but mortality rates remained stable. Analysis of competing treatment strategies for immediate decompression demonstrates decreasing utilization of PCN, which showed higher rates of adverse outcomes. These findings should be viewed as preliminary and hypothesis generating, demonstrating the pressing need for further study.
感染性尿石症的发病率尚不清楚,并且描述最佳治疗策略的证据也存在争议。
研究美国感染性尿石症的趋势、竞争治疗方法的实践模式,并比较不良结局。
设计、地点和参与者:从 1999 年至 2009 年全国住院患者样本(Nationwide Inpatient Sample)中提取了 396385 名成年感染性尿石症住院患者的加权估计值。
时间趋势分析检查了感染性尿石症和相关败血症的发病率,以及逆行输尿管导管插入术和经皮肾造口术(PCN)用于紧急/紧急减压的比率。倾向评分匹配比较了不同方法的不良结局发生率。
在 1999 年至 2009 年间,女性中感染性尿石症的发病率从 15.5(95%置信区间[CI],15.3-15.6)增加到 27.6(27.4-27.8)/100000);男性从 7.8(7.7-7.9)增加到 12.1(12.0-12.3)/100000。相关败血症的发生率从 6.9%增加到 8.5%(p=0.013),严重败血症从 1.7%增加到 3.2%(p<0.001);死亡率保持稳定,为 0.25-0.20%(p=0.150)。在立即减压的患者中,有 113459 名(28.6%)患者接受 PCN 治疗,其使用率从 16.1%降至 11.2%(p=0.001),且存在明显的区域差异。在匹配分析中,PCN 显示出更高的败血症发生率(比值比[OR]:1.63;95%CI,1.52-1.74)、严重败血症发生率(OR:2.28;95%CI,2.06-2.52)、更长的住院时间(OR:3.18;95%CI,3.01-3.34)、更高的住院费用(OR:2.71;95%CI,2.57-2.85)和死亡率(OR:3.14;95%CI,13-4.63)。然而,观察性数据排除了对结局与干预之间的时间关系和疾病严重程度的评估。
在 1999 年至 2009 年间,女性患感染性尿石症的可能性是男性的两倍。相关败血症和严重败血症的发生率增加,但死亡率保持稳定。对立即减压的竞争治疗策略的分析表明,PCN 的使用率下降,但其不良结局发生率更高。这些发现应被视为初步和假设生成的结果,表明迫切需要进一步研究。